Cerus reported $19.96M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Cerus USD 19.96M 4.29M Dec/2025
GRIFOLS EUR 513M 189M Jun/2026
Haemonetics USD 223.38M 22.06M Jun/2026
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 160.58M 16.38M Jun/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Quidel USD 123.4M 17M Jun/2026
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 148.58M 16.72M Jun/2026
Terumo JPY 280.49B 63.34B Mar/2026
Utah Medical Products USD 84.27M 2.09M Sep/2025